Table 1. Synthesis of 2-(Arylthio)arylcyanamides: Optimization
Table 2. Reactions of Aryl Halidesa
of the Reaction Conditionsa
product(s) (%)b
product(s) (%)b
entry
X
Y
A
B
entry
catalyst
base
solvent time (h)
A
B
1
I
I
I
I
Br
Cl
100
20
<5
10
n.d.
n.d.
n.d.
n.d.
90
1
2
3
4
6
7
8
9
CuSO4·5H2O Cs2CO3 DMSO
CuSO4·5H2O K2CO3 DMSO
CuSO4·5H2O K3PO4 DMSO
CuSO4·5H2O Cs2CO3 DMF
CuSO4·5H2O Cs2CO3 Toluene
CuSO4·5H2O Cs2CO3 1,4-dioxane
CuSO4·5H2O Cs2CO3 CH3CN
CuSO4·5H2O Cs2CO3 2-propanol
3
6
6
5
6
6
6
6
5
5
3
3
3
3
3
3
100
100
45
n.d.
n.d.
55
n.d
100
100
60
100
35
41
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
2c
3d
4
Br
Cl
I
100
n.d.
n.d.
40
5
I
100
a Thiourea (0.5 mmol), aryl halide (0.5 mmol), CuSO4·5H2O (2.5 mol
%), and Cs2CO3 (0.75 mmol) were stirred at 90 °C for 3 h in DMSO (1
mL). b Determined by 1H NMR. c N-(2-Bromophenyl)cyanamide obtained
in 70% yield as a byproduct. d N-(2-Chlorophenyl)cyanamide obtained in
82% yield as a byproduct.
n.d.
10 CuSO4·5H2O Cs2CO3 DMSO
11 CuSO4·5H2O Cs2CO3 DMSO
65c
59d
100
100
100
100
100
100
12 CuI
Cs2CO3 DMSO
Cs2CO3 DMSO
Cs2CO3 DMSO
Cs2CO3 DMSO
Cs2CO3 DMSO
13 CuBr
14 Cu2O
15 CuBr2
16 CuCl2·2H2O
when the reaction was pursued at 90 °C using 2.5 mol % of
the copper salts such as CuSO4·5H2O, CuI, CuBr, Cu2O,
CuBr2, CuCl2·2H2O, and Cu(OAc)2·H2O in the presence of
Cs2CO3 in DMSO affording the desired 2-(phenylthio)phe-
nylcyanamide A in 100% conversion. The reactions with
solvent, DMF, and base, K2CO3, required longer reaction
time to afford A in quantitative yield. In contrast, solvents
such as toluene, 1,4-dioxane, CH3CN, and 2-propanol, and
base, K3PO4, were less effective providing either aminoben-
zothiazole9 B or a mixture of A and B as the product(s).
Similarly, lowering of the reaction temperature (80 °C) or
base (1 equiv) led to the formation of a mixture of A and B.
The control experiment confirmed that in the absence of the
copper salts no reaction occurred.
17 Cu(OAc)2·H2O Cs2CO3 DMSO
a N-(2-Iodophenyl)thiourea (0.5 mmol), iodobenzene (0.5 mmol), copper
catalyst (2.5 mol %), and base (0.75 mmol) were stirred at 90 °C for an
appropriate time in solvent (1 mL). Determined by H NMR. c Cs2CO3
b
1
(0.5 mmol) used. d Reaction temperature 80 °C. n.d. ) not detected.
substituents are compatible with this protocol to provide the
rearranged cross-coupled 2-thioarylcyanamides in high yield.
The optimization of the reaction conditions was carried
out with N-(2-iodophenyl)thiourea and iodobenzene as model
substrates using different bases, solvents, and copper sources
at varied temperatures (Table 1). The best result was obtained
(3) For some studies on cyanamide synthesis, see: (a) Kaupp, G.;
Schmeyers, J.; Boy, J. Chem.sEur. J. 1998, 4, 2467–2474. (b) Sato, R.;
Itoh, K.; Itoh, K.; Nishina, H.; Goto, T.; Saito, M. Chem. Lett. 1984, 1913–
1916. (c) Bakunov, S. A.; Rukavishnikov, A. V.; Tkachev, A. V. Synthesis
2000, 1148–1159. (d) Chen, C.-Y.; Wong, F. F.; Huang, J. J.; Lin, S.-K.;
Yeh, M.-Y. Tetrahedron Lett. 2008, 49, 6505–6507. (e) Chaudhuri, K. H.;
Mahajan, U. S.; Bhalerao, D. S.; Akamanchi, K. G. Synlett 2007, 2815–
2818.
The reactions of the aryl halides were next screened using
CuSO4·5H2O as a catalyst. Iodobenzene proceeded cross-
coupling with N-(2-iodophenyl)thiourea to give 2-(phenyl-
thio)phenylcyanamide A in 100% conversion. In contrast,
bromobenzene and chlorobenzene exhibited moderate reac-
tivity yielding either a mixture of A and B or B as the
product(s) (Table 2). In contrast, N-(2-bromo-) and N-(2-
chlorophenyl)thioureas proceeded reactions with iodobenzene
to afford A in <20% yield along with 2-halophenylcyana-
mide.
Encouraged by these results, we further pursued the scope
of the process with respect to the other substrates. Aryl
iodides having 2-Cl, 2-OMe, 3-NO2, 4-NH2, 4-Cl, 4-OMe,
4-NO2, 2,4-di-Me, 2,5-di-Me, 2,6-di-Me, 3,4-di-Me, and 3,5-
di-Me substituents and 1-naphthyl iodide proceeded reactions
with N-(2-iodo-4-methylphenyl)thiourea to give the corre-
sponding 2-(arylthio)arylcyanamide in 83-98% yield (Table
(4) For structure and reactivity of cyanamides, see: (a) Sandler, S. R.;
Karo, W. Organic Functional Group Preparations; Academic: New York,
1972; Vol. 3, pp 286-287. (b) Miyasaka, H.; Clerac, R.; Campos-Fernandez,
C. S.; Dunbar, K. R. Inorg. Chem. 2001, 40, 1663–1671. (c) Hollebone,
B. R.; Nyholm, R. S. J. Chem. Soc. A 1971, 332–337. (d) Pombeiro, A. J. L.
Inorg. Chim. Acta 1992, 198, 179–186. (e) Kamijo, S.; Jin, T.; Yamamoto,
Y. Angew. Chem., Int. Ed. 2002, 41, 1780–1782. (f) Brand, H.; Mayer, P.;
Schulz, A.; Soller, T.; Villinger, A. Chem. Asian J. 2008, 3, 1050–1058.
(g) Renodon-Corniere, A.; Dijols, S.; Perollier, C.; Lefevre-Groboillot, D.;
Boucher, J.-L.; Attias, R.; Sari, M.-A.; Stuehr, D.; Mansuy, D. J. Med.
Chem. 2002, 45, 944–954. (h) Hughes, T. V.; Hammond, S. D.; Cava, M. P.
J. Org. Chem. 1998, 63, 401–402.
(5) McCall, J. M.; TenBrink, R. E.; Ursprung, J. J. J. Org. Chem. 1975,
40, 3304–3306.
(6) (a) Hu, L. Y.; Guyo, J.; Magar, S. S.; Fischer, J. B.; Burke-Howie,
K. J.; Durant, G. J. J. Med. Chem. 1997, 40, 4281–4289. (b) Robinson,
J. R.; Brown, W. H. Can. J. Chem. 1951, 29, 1069–1074.
(7) (a) Gilman, G.; Goodman, L. S.; Rall, T. W.; Murad, F. Goodman
and Gilman’s The Pharmacological Basis of Therapeutics, 7th ed.;
Pergamon Press: New York, 1990; p 89. (b) Saneyoshi, M.; Tokuzen, R.;
Maeda, M.; Fukuoka, F. Chem. Pharm. Bull. 1968, 16, 505–508. (c) Nickon,
A.; Fieser, L. F. J. Am. Chem. Soc. 1952, 74, 5566–5570. (d) Jia, Q.; Cai,
T.; Huang, M.; Li, H.; Xian, M.; Poulos, T. L.; Wang, P. G. J. Med. Chem.
2003, 46, 2271–2274. (e) Kumar, L.; Kaushik, M. P.; Mazumdar, A. Eur.
J. Org. Chem. 2008, 1910–1916.
(8) (a) Donetti, A.; Omodei-Sale, A.; Mantegani, A. Tetrahedron Lett.
1969, 39, 3327–3328. (b) Pala, G.; Mantegani, A.; Zugna, E. Tetrahedron
1970, 26, 1275–1279. (c) Currie, A. C.; Newbold, G. T.; Spring, F. S.
J. Chem. Soc. 1961, 4693–4700.
(9) (a) Ding, Q.; He, X.; Wu, J. J. Comb. Chem. 2009, 11, 587–591.
(b) Wang, J.; Peng, F.; Jiang, J.; Lu, Z.; Wang, L.; Bai, J.; Pan, Y.
Tetrahedron Lett. 2008, 49, 467–470.
Org. Lett., Vol. 12, No. 1, 2010
85